Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Doximity (DOCS – Research Report), RayzeBio, Inc. (RYZB – Research Report) and Edgewise Therapeutics (EWTX – Research Report).
Doximity (DOCS)
Truist Financial analyst Jailendra Singh maintained a Hold rating on Doximity on November 14 and set a price target of $28.00. The company’s shares closed last Thursday at $25.40.
According to TipRanks.com, Singh is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Doximity has an analyst consensus of Hold, with a price target consensus of $25.50, which is a 1.1% upside from current levels. In a report issued on November 6, Piper Sandler also maintained a Hold rating on the stock with a $21.00 price target.
See today’s best-performing stocks on TipRanks >>
RayzeBio, Inc. (RYZB)
Truist Financial analyst Robyn Karnauskas maintained a Buy rating on RayzeBio, Inc. on November 14 and set a price target of $29.00. The company’s shares closed last Thursday at $21.28.
According to TipRanks.com, Karnauskas is a 4-star analyst with an average return of
RayzeBio, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $31.33.
Edgewise Therapeutics (EWTX)
In a report issued on November 14, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Edgewise Therapeutics, with a price target of $25.00. The company’s shares closed last Thursday at $6.35.
According to TipRanks.com, Devarakonda ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Edgewise Therapeutics with a $26.40 average price target, implying a 302.4% upside from current levels. In a report issued on November 9, RBC Capital also maintained a Buy rating on the stock with a $28.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DOCS:
